News and Opinions
Will the US biotech funding surge trigger a renaissance in the global biotech industry?
By Jules Adam - Labiotech - In recent months, the United States has witnessed a remarkable resurgence in biotech investments, marking a significant turnaround from the preceding challenges faced by the sector. This revival is characterized by a robust increase in...
April 23-25 Online “Live Stream” – The ATMP Sweden World Tour 2024 – Bernard Siegel among guest speakers
By ATMP Sweden – It’s that time of year again, time to register for the ATMP world tour! We are very excited this year to host Peter Marks from the FDA and Bernard Siegel founder of the World Stem Cell Summit, Regenerative Medicine Foundation. and more recently...
Degree of cell crowding in the early human embryo influences cell identity decision, new culture system finds
By Babraham Institute Research conducted by Dr Shota Nakanoh in a collaboration between Dr Teresa Rayon’s lab at the Institute and Professor Ludovic Vallier’s lab at the Wellcome-MRC Cambridge Stem Cell Institute has determined that the degree of cell crowding in the...
Scientists develop a rapid gene-editing screen to find effects of cancer mutations
By Anne Trafton - MIT NEWS - With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies. Tumors can carry mutations in hundreds of different genes, and each of those genes may be mutated in different ways — some...
150 Organizations Join the Healthspan Action Coalition’s Mission to Extend Healthy Longevity
Milestone Announced at the Inaugural Livelong Summit in West Palm Beach West Palm Beach, FL, March 15, 2024—The Healthspan Action Coalition today announced a major milestone—the joining of 150 organizations in its global mission to extend healthy longevity to all...
Livelong Summit | Live Long. Live Better. A powerful two-day event.
JOIN US at the Pam Beach Convention Center, Friday, March 15 and Saturday, March 16. The Livelong Summit, March 15 & 16, with our very own Bernard Siegel speaking. This exclusive 2-day event features some of the greatest minds in medicine and longevity science....
2024 Annual World Congress – Society of Brain Mapping & Therapeutics
MARCH 14 - 17, 2024 The program will represent state-of-the-art science and technology in the field of neuroscience, engineering, neurosurgery, psychiatry, psychology, molecular biology, neurology, radiology and oncology. Melissa King organized the regenerative...
Brad Inman, Creator of Livelong Summit and Bernie Siegel, founder of HSAC, discuss the Livelong Summit happening March 15-16 in Palm Beach, FL
Watch the recorded LinkedIn Video - Click Here In this video Bernie & Brad discuss the life-changing Livelong Summit coming to Palm Beach Convention Center on March 15 & 16, sponsored by the Healthspan Action Coalition. To learn more & to register for the...
MEGA-CRISPR tool gives a power boost to cancer-fighting cells
By Sara Reardon - Nature - The CRISPR–Cas9 gene-editing system excels at altering and disrupting genes. But the changes it makes are permanent, which can be a big problem if the system goes awry. Now, a CRISPR-based system that targets a cell’s short-lived messenger...
US biotech fundraising boom ends 2-year deal drought
By Nicholas Megaw - Fianacial Times - Biotech companies are rushing to raise money in US equity markets at the fastest rate since the peak of the mid-pandemic market boom. Drug developers raised $6.2bn in equity capital markets in January, according to data from...
Gene Signature May Predict Response to Immunotherapy for Non-Small Cell Lung Cancer
By Weill Cornell Medicine - A new study identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small cell lung cancer (NSCLC) treated with a combination of immunotherapy and low-dose radiation. The results, published in...
FDA approves first cell therapy for solid tumors
by Megan Giboney - RegMedNet - The US FDA has granted accelerated approval for AMTAGVI™ (lifileucel), a novel cell therapy for advanced melanoma. This is the first cell therapy to be approved by the FDA for the treatment of a solid tumor. AMTAGVI utilizes a population...
Boosting health equity with lab-grown tissues
By University of California Irvine - Popular Science recently chose Quinton Smith, UC Irvine assistant professor of chemical and biomolecular engineering, as one of its Brilliant 10 scientists “on the cusp of changing the world” for his research on growing tissue from...
Livelong Summit: Key Longevity Trends for Medical Professionals
By the HSAC TEAM Healthspan Action Coalition (HSAC) is sponsoring The Livelong Summit™ to bring you an exclusive 2-day event featuring some of the greatest minds in medicine and longevity science. Because so many medical professionals have already signed up, we’ve...
New CRISPR tool accelerates and optimizes genome editing
By April Wendling, University of Illinois at Urbana-Champaign - Phys.org - CRISPR/Cas systems have undergone tremendous advancement in the past decade. These precise genome editing tools have applications ranging from transgenic crop development to gene therapy and...
5 surprising reasons why you should donate blood
By U. Rochester-URMC - Futuirity - The American Red Cross is experiencing the most critical blood shortage in 20 years. Blood shortages are all too common, but they’re occurring more frequently now than ever before. Contact the Red Cross to find local blood drives...
Studying “Stone Man Syndrome,” Scientists Inadvertently Improve Cellular Reprogramming
Ben Andrew Henry - The Scientist - While studying a rare genetic disease, researchers discovered a signaling pathway linked to the efficiency of reprogramming somatic cells into stem cells. Thanks to a chance discovery, researchers have found a more efficient way to...
Thermo Fisher expands partnership with Multiply Labs to automate cell therapy production
By Joseph Keenan - Fierce Pharma - Robotics specialist Multiply Labs and Thermo Fisher Scientific inked a deal to expand their partnership to further automate the cell therapy production process. The two companies will integrate Multiply Lab's robotic technology and...
Artificial cartilage with the help of 3D printing
By Tu Wien News A new approach to producing artificial tissue has been developed at TU Wien: Cells are grown in microstructures created in a 3D printer. Is it possible to grow tissue in the laboratory, for example to replace injured cartilage? At TU Wien (Vienna), an...
FDA accepts first AI algorithm to drug development tool pilot, with Deliberate AI’s anxiety and depression assessment
By Andrea Park -Fierce Biotech - For the first time since it launched in 2020 and began accepting submissions in 2022, a program started by the FDA to provide support for unconventional drug development tools has accepted its first artificial intelligence-powered...
Join Regenerative Medicine Foundation
Join today and get access to our newsletter and exclusive updates about events
and all things happening with regenerative medicine.
Join Our Mailing List
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.



















